RNA - PTC Therapeutics rallies 18% on EU authorization update for Translarna
2024-05-20 09:58:45 ET
More on PTC Therapeutics
- PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts
- PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
- PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript
- PTC Therapeutics wins FDA priority review for gene therapy
- PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M